Login / Signup

A nano-innate immune system activator for cancer therapy in a 4T1 tumor-bearing mouse model.

Xiang-Yu LiuMao-Hua ZhuXiao-Yu WangXiao DongHai-Jun LiuRui-Yang LiShi-Chong JiaQin LuMei ZhaoPeng SunHong-Zhuan ChenChao Fang
Published in: Journal of nanobiotechnology (2022)
The antitumor potency conferred by NISA highlights the significance of stimulating multiple innate immune elements in cancer immunotherapy.
Keyphrases
  • innate immune
  • cancer therapy
  • mouse model
  • drug delivery
  • nuclear factor
  • immune response